
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [RARE] Ultragenyx Pharmaceutical Inc
Data updated 2025-Jul-09 (Wednesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-Jul-09 Wednesday
Open | $39.97 | High | $42.37 +6.00% |
---|---|---|---|
Close | $41.44 | Low | $39.70 -0.68% |
Volume | 2.16 Million 1.11x | Volatility | 6.73% |
Change |
+$2.02
+5.12%
|
Streak | ↑ 1 days +5.12% |
20d SMA | $37.88 +9.4% | 50d SMA | $36.90 +12.3% | 100d SMA | $37.63 +10.1% | 200d SMA | $42.99 -3.6% |
RSI | 69 | MACD | 0.38 | ADX | 17.4 | Stochastic Oscillator | 87.7 90.3 |
CCI | 210.5 | ATR | 1.63 | OBV | 23.5 Million | Chaikin A/D | 24.9 Million |
Market Cap | 3.88 B | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 7.97 | Price/Book (mrq) | 14.1 | EV/Revenue (ttm) | 7.7 | EV/EBITDA (ttm) | -6.47 |
% Held by Insiders | 4.11% | % Held by Institutions | 101.06% | Shares Short | 3.78 M | Shares Short (prior month) | 3.56 M |
Short Ratio | 4.87 | Short % of Outstanding | 4.59% | Short % of Float | 5.24% | Shares Short Change (mom) | +6.2% |
Revenue/Share (ttm) | $5.91 | Profit Margin (ttm) | -139.70% | Operating Margin (ttm) | -95.81% | EBITDA (ttm) | -543 M |
Diluted EPS (ttm) | $-8.25 | Current Ratio (mrq) | 2.61 | Return on Assets (ttm) | -23.43% | Return on Equity (ttm) | -193.23% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | 23.30% | Operating Cash Flow (ttm) | -475 M | Free Cash Flow (ttm) | -283 M | |
Choose view type
Monthly Performance for Ultragenyx Pharmaceutical Inc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Ultragenyx Pharmaceutical Inc up to close of 2025-Jul-09 at $41.44
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+14.29%
|
-2.2%
|
+13.6%
|
16.1%
|
+3.7%
|
+4.1%
|
1.11x
|
02 Trailing 10-days
|
|
+11.52%
|
-2.2%
|
+16.7%
|
19.3%
|
+8.0%
|
+6.5%
|
1.06x
|
03 Trailing 20-days
|
|
+11.88%
|
-2.2%
|
+16.7%
|
19.3%
|
+9.4%
|
+8.9%
|
1.10x
|
04 Trailing 30-days
|
|
+16.21%
|
-2.2%
|
+23.8%
|
26.6%
|
+11.4%
|
+10.0%
|
1.13x
|
05 Trailing 50-days
|
|
+8.80%
|
-2.2%
|
+26.5%
|
29.3%
|
+12.3%
|
+10.7%
|
1.10x
|
06 Trailing 100-days
|
|
-4.58%
|
-10.4%
|
+40.0%
|
56.4%
|
+10.1%
|
+7.7%
|
1.11x
|
07 Trailing 200-days
|
|
-28.18%
|
-30.8%
|
+40.0%
|
102.4%
|
-3.6%
|
+1.4%
|
1.04x
|
08 Month-to-date
|
|
+13.97%
|
-2.2%
|
+16.7%
|
19.3%
|
|
|
|
09 Quarter-to-date
|
|
+13.97%
|
-2.2%
|
+16.7%
|
19.3%
|
|
|
|
10 Year-to-date
|
|
-1.50%
|
-10.9%
|
+40.0%
|
57.1%
|
|
|
|
11 Trailing 52-weeks
|
|
-1.92%
|
-31.4%
|
+40.0%
|
104.0%
|
|
|
|
1-week Performance Benchmarks for Ultragenyx Pharmaceutical Inc:
Related to Ultragenyx Pharmaceutical Inc
Information for Ultragenyx Pharmaceutical Inc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-09 on Google
SEC Reports : Quarterly reports around 2025-Jul-09 on SEC Edgar
Compare Ultragenyx Pharmaceutical Inc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Ultragenyx Pharmaceutical Inc
Industry : Biotechnology industry performance which includes Ultragenyx Pharmaceutical Inc